As of Aug 26
| +0.13 / +1.07%|
The 6 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 19.50, with a high estimate of 24.00 and a low estimate of 16.00. The median estimate represents a +59.44% increase from the last price of 12.23.
The current consensus among 6 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.